CMS should address Medicare's flawed payment system for DME infusion drugs.
CMS should address Medicare's flawed payment system for DME infusion drugs.
Centers for Medicare & Medicaid Services should address Medicare's flawed payment system for DME infusion drugs
- 1 online resource (11 pages) : color illustrations
Title from title screen (viewed Oct. 21, 2016). "August 2016." "OEI-12-16-00340." "Report in Brief." "HHS OIG Recommendation Followup." CRDP Project record.
Includes bibliographical references (pages 10-11).
Centers for Medicare & Medicaid Services (U.S.)--Auditing.
Medicare--Finance.
Infusion therapy--Equipment and supplies--Costs.--United States
Drugs--Finance--Government policy--United States.
Waste in government spending--United States.
0445-B-07 (online)
HE 1.75:OEI-12-16-00340
OEI-12-16-00340
Title from title screen (viewed Oct. 21, 2016). "August 2016." "OEI-12-16-00340." "Report in Brief." "HHS OIG Recommendation Followup." CRDP Project record.
Includes bibliographical references (pages 10-11).
Centers for Medicare & Medicaid Services (U.S.)--Auditing.
Medicare--Finance.
Infusion therapy--Equipment and supplies--Costs.--United States
Drugs--Finance--Government policy--United States.
Waste in government spending--United States.
0445-B-07 (online)
HE 1.75:OEI-12-16-00340
OEI-12-16-00340